nivolumab
bms
['nivolumab', 'nivo']
the addition of low dose nivolumab (20mg every 3 weeks) to metronomic chemo in relapsed -recurrent or newly diagnosed advanced hnscc improves overall survival 
Professor of Medical Oncology,  Amrita Institute of Medical  Sciences. Oncologist and Hematologist